The impact of immune checkpoint inhibitors in patients with chronic lymphocytic leukemia (CLL): A protocol for a systematic review and meta-analysis of randomized controlled trials

INTRODUCTION: The global burden of chronic lymphocytic leukemia (CLL) has constantly increased over the years, with a current incidence of 3.5 cases per 100,000 people. Although the conventional drugs used to treat CLL patients have been effective treatment failure rate in some of the patients is al...

Descripción completa

Detalles Bibliográficos
Autores principales: Ntsethe, Aviwe, Dludla, Phiwayinkosi Vusi, Nyambuya, Tawanda Maurice, Ngcobo, Siphamandla Raphael, Nkambule, Bongani Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360255/
https://www.ncbi.nlm.nih.gov/pubmed/32664154
http://dx.doi.org/10.1097/MD.0000000000021167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360255/
https://www.ncbi.nlm.nih.gov/pubmed/32664154
http://dx.doi.org/10.1097/MD.0000000000021167

Ejemplares similares